Products for Research Use Only

SingleFlowEx CD99 PE

CAT: 0270-ED7202Size: 1 mLDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0270-ED7202Size:1 mL
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
SingleFlowEx is fluorochrome-labeled monoclonal antibody single reagent for use in laboratory-developed multicolor flow cytometry tests in order to examine human clinical samples. SingleFlowEx can be used in various multicolor combinations. Laboratory shall establish the SingleFlowEx performance characteristics in conjunction with other reagents in normal and pathological samples.
Certification
RUO (GMP)
Clone
3B2/TA8
Applications
FC (QC tested)
Concentration
0.050 mg/mL
Format
PE
Buffer
Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
Components
1 vial of monoclonal antibody reagent.The content (1 mL) is sufficient for min. 100 Tests.
References & Citations
*Kueng HJ, Leb VM, Haiderer D, Raposo G, Thery C, Derdak SV, Schmetterer KG, Neunkirchner A, Sillaber C, Seed B, Pickl WF: General strategy for decoration of enveloped viruses with functionally active lipid-modified cytokines. J Virol. 2007 Aug;81 (16) :8666-76., URL: http://www.ncbi.nlm.nih.gov/pubmed/17537846 , *Pickl WF, Pimentel-Muiñ os FX, Seed B: Lipid rafts and pseudotyping. J Virol. 2001 Aug;75 (15) :7175-83., URL: http://www.ncbi.nlm.nih.gov/pubmed/11435598 , *Brémond A, Meynet O, Mahiddine K, Coito S, Tichet M, Scotlandi K, Breittmayer JP, Gounon P, Gleeson PA, Bernard A, Bernard G: Regulation of HLA class I surface expression requires CD99 and p230/golgin-245 interaction. Blood. 2009 Jan 8;113 (2) :347-57., URL: http://www.ncbi.nlm.nih.gov/pubmed/18849489 , *Waclavicek M, Majdic O, Stulnig T, Berger M, Sunder-Plassmann R, Zlabinger GJ, Baumruker T, Stöckl J, Ebner C, Knapp W, Pickl WF: CD99 engagement on human peripheral blood T cells results in TCR/CD3-dependent cellular activation and allows for Th1-restricted cytokine production. J Immunol. 1998 Nov 1;161 (9) :4671-8., URL: http://www.ncbi.nlm.nih.gov/pubmed/9794396, *Weijler L, Kowarsch F, Wödlinger M, Reiter M, Maurer-Granofszky M, Schumich A, Dworzak MN: UMAP based anomaly detection for minimal residual disease quantification within acute myeloid leukemia. Cancers (Basel) 2022 Feb 11;14 (4) :898., URL: https://pubmed.ncbi.nlm.nih.gov/35205645/, *Use of this product has not been published., URL:
Storage Conditions
Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.